|
| Board of Advisors | Council of Journalists | BioAgenda Team |
updated 07 Feb 2006 10:54
Click on names for detailed bios
Board of Advisors
BioAgenda is supported by a Board of Advisors representing the leading edge of biotech research and business. These board members are actively engaged with Editorial Director David Ewing Duncan to shape the topics to be addressed at the conference. Board members, to date, include:
- Alex Barkas, PhD, Managing Director, Prospect Venture Partners
- Seth Berkley, MD, President, CEO and Founder, International AIDS Vaccine Initiative (IAVI)
- G. Steven Burrill, Founder and CEO, Burrill & Company
- Brook Byers, Partner, Kleiner Perkins Caufield & Byers
- Charles Cantor, PhD, Director, Center for Advanced Biotechnology at Boston College; Co-Founder and CSO, Sequenom
- Arthur Caplan, PhD, Director of the Center for Bioethics, University of Pennsylvania
- Nathaniel Eames David, PhD, Co-Founder and CSO, AESTHERx
- Geoffrey Duyk, MD, PhD, Managing Director, TPG Ventures
- Jean-François Formela, MD, Senior Partner, Atlas Venture
- Frederick Frank, Vice Chairman, Lehman Brothers
- Corey Goodman, PhD, President and CEO, Renovis; Professor of Neurobiology, University of California, Berkeley
- Baroness Susan Greenfield, PhD, Fullerian Professor of Physiology and Comparative Anatomy at Oxford University; Director, Royal Institution of Great Britain; Member, House of Lords
- Steven H. Holtzman, President, CEO, and Co-Founder, Infinity Pharmaceuticals
- Leroy Hood, MD, PhD, Co-Founder and President, Institute for Systems Biology
- Bruce W. Jenett, JD, Shareholder, Heller Ehrman LLP
- Cynthia Kenyon, PhD, Herbert Boyer Distinguished Professor of Biochemistry and Biophysics, University of California, San Francisco
- Edison Liu, MD, Executive Director, Genome Institute of Singapore
- Nola E. Masterson, Founder and CEO, Science Futures, Inc.
- Cynthia Robbins-Roth, PhD, Founder, BioVenture Publishing, Inc. and BioVenture Consultants; Journalist and best-selling author of From Alchemy to IPO
- Anthony Russo, PhD, CEO, Noonan Russo, a division of EURO RSCG Life PR
- Kari Stefansson, MD, CEO and Co-Founder, deCODE Genetics
- Gregory Stock, PhD, CEO, Signum Biosciences; Director, Program on Medicine, Technology and Society, UCLA
back to top
Council of Journalists
Distinguished journalists will advise on issues and policies to assure objectivity and journalistic integrity, Council members, to date, include:
- Chris Anderson, Editor-in-Chief, WIRED Magazine
- Jonathan Leake, Science and Environment Editor, The Sunday Times of London
- Stephen Petranek, Editor-in-Chief, Discover Magazine
- Peter Petre, Senior Editor-at-Large, Fortune Magazine
- Jason Pontin, Editor-in-Chief and Publisher, MIT Technology Review
back to top
BioAgenda Team
|
